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In this issue of Structure, Beale et al. (2015) define structurally and functionally a large extracellular domain
unique to mammalian peptide transporters and its implications for the transport of basic di- and tri-peptides
(Beale et al., 2015).In mammals, the uptake of diet-derived
di- and tri-peptides, as well as pharma-
ceutically important drug molecules such
as antibiotics and anti-viral medications,
is mediated by PepT1 and PepT2, mem-
bers of the conserved proton-dependent
oligopeptide transporter (POT) family.
The POT family belongs to the major
facilitator superfamily (MFS), members
of which contain 12 transmembrane (TM)
helices that form two domains each
containing six TM helices related by a
pseudo two-fold symmetry.
Early crystal structures of bacterial
POT members revealed the architecture
of the transporter in a number of distinct
transport states (Newstead et al., 2011;
Solcan et al., 2012). Significant attention
has lately been focused on investigating
the substrate binding site promiscuity for
both PepT1 and PepT2 and the tailoring
of pro-drugs in an effort to improve the
uptake of poorly absorbed or retained
medications via these transporters (see
Brandsch, 2013, for review). These ef-
forts have been complemented by re-
cent structures of bacterial POT homo-logs in complex with natural and
unnatural di- and tri-peptides, revealing
at least two binding modes for di- and
tri-peptides depending on their amino
acid composition (Doki et al., 2013;
Guettou et al., 2014; Lyons et al.,
2014). Subsequent thermodynamic mea-
surements on PepT from Streptococcus
thermophilus supported a two transport
mechanism model as underscored by
the different measured proton:peptide
transport stoichiometries for di- and
tri-peptides (Parker et al., 2014).
Together, these results provide a plat-
form from which to also guide pro-drug
development.
Comparison of the various peptide-
transporter complexes highlight an asym-
metry to the domain movements where
the transition from the occluded to the in-
ward open state is via bulk movements
of the C-terminal domain. This asymmet-
rical movement of the TM helices of the
C-terminal bundle is largely incompatible
with the classic rigid-body rocker-switch
model of transport as proposed from
structural studies on GlpT and LacY(Abramson et al., 2003; Huang et al.,
2003). As an alternative mechanism, it
has been postulated that a dynamic
movement of helices within the two six-
helix bundles is required for the substrate
binding site to be alternately accessible
to both sides of the membrane (Fowler
et al., 2015). Similar observations were
first highlighted for a plant phosphate
transporter, where contrary to the peptide
transporter, the N-terminal bundle un-
dergoes the analogous movements (Ped-
ersen et al., 2013).
A significant difference between bacte-
rial, fungal, plant and mammalian peptide
transporters has long been known though
from topology and sequence analyses
that identified the presence of a sizeable
extracellular ‘‘loop’’ exclusive to the
mammalian transporters. This additional
sequence is located between TM helices
9 and 10 of the C-terminal TM bundle and
is not assigned with any function. Here,
the authors shed light on the structure
and function of this extracellular loop,
revealing that it is comprised of two
consecutive immunoglobulin-like domainsª2015 Elsevier Ltd All rights reserved 1779
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Figure 1. Schematic Diagrams of Human PepT1 and the
Streptococcus thermophilus Peptide Transporter PepTSt
(A) The mammalian PepT1 contains a large extracellular loop between helices
9 and 10 that Beale et al. (2015) show to consist of two immunoglobulin-fold
domains that appear to interact with the intestinal protease trypsin.
(B) Bacterial peptide transporters have two additional TM helices inserted
between the two 6 TM repeat units that are placed at the periphery of the
transporter core. This insert might serve to associate with membrane-bound
proteases.
Structure
Previews(Figure 1). Of particular note,
however, is that the removal
of these extracellular domains
(ECD) from PepT2 had no sig-
nificant effect on the core
transport activity for peptides
or the antibiotic cefaclor.
Using surface plasmon reso-
nance and microscale ther-
mophoresis studies to analyze
putative interaction partners,
the authors found transient
binding of the intestinal prote-
ase trypsin to the ECD with a
micromolar binding constant,
high enough to propose a
relevant interaction at the
significant concentrations of
trypsin in the small intestinal
mucosa. This binding was
attributed to the presence of
two highly conserved acidic
residues in the ECD, muta-
tions of which abolished
trypsin binding.
Based on the transient
complex formation between
the ECD and trypsin as
well as prior reports of trypsin
localizing to and binding
the mucosa of the small
intestine, the authors present
an enticing, yet speculative,
physiological role for this
complex (Beale et al., 2015).
They propose that the adap-tation to include an ECD to sequester
trypsin results in an increase in the local
concentration of di- and tri-peptides con-
taining basic residues in the vicinity of the
transporter. As the transport of basic
peptides by PepT1 is less efficient, this
serves also to overcome this hurdle, thus
promoting their transport. While the
trypsin-ECD interaction has been verified
in vitro, in vivo confirmation and analysis
of such an interaction will be an important
next step in verifying its physiological role.
Furthermore, the proposed increase of
transport of positively charged peptides
due to trypsin will also need to be shown
in vitro.
Such a modular adaptation to the clas-
sical MFS scaffold supports an intriguing
avenue by which evolution adds sophisti-
cation to a target protein without adverse1780 Structure 23, October 6, 2015 ª2015 Elconsequences to its core function. Inter-
estingly, the bacterial PepT structures to
date contain two TM helices that are
inserted between the N- and C-terminal
domains, i.e., between TM 6 and 7, and
are designated Ha and Hb (Figure 1).
These helices, which are unique to bacte-
rial members, form a hairpin in the mem-
brane and are located in the periphery of
the MFS fold; their function to-date re-
mains unclear. It is tempting to speculate
that these additional helices also serve to
associate appropriate membrane-associ-
ated or membrane-inserted proteases to
the transporter.
In summary, the new structures of the
PepT ECDs offer an important extension
on the knowledge derived from structural
and functional studies on bacterial pep-
tide transporters, thus increasing oursevier Ltd All rights reservedcurrent understanding of pep-
tide and drug uptake in
mammals and, in general,
how the MFS has adapted to
integrate additional structural
elements to improve function
in eukaryotic systems. More-
over, future studies that aim
to establish the physiological
role of the trypsin ECD
interactions will be of great
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